Janux Therapeutics
JANX
#4351
Rank
โ‚ฌ1.70 B
Marketcap
28,88ย โ‚ฌ
Share price
-1.45%
Change (1 day)
-20.75%
Change (1 year)

Operating Margin for Janux Therapeutics (JANX)

Operating Margin as of March 2025 (TTM): -651.62%

According to Janux Therapeutics's latest financial reports and stock price the company's current Operating Margin is -651.62%. At the end of 2024 the company had an Operating Margin of -651.62%.

Operating Margin history for Janux Therapeutics from 2021 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-651.62%-9.64%
2023-721.18%-1.51%
2022-732.22%-18.49%
2021-898.32%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.